Farnesyl transferase inhibitors: the successes and surprises of a new class of potential cancer chemotherapeutics
- 31 December 1995
- journal article
- review article
- Published by Elsevier in Chemistry & Biology
- Vol. 2 (12) , 787-791
- https://doi.org/10.1016/1074-5521(95)90083-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional ConsequencesAnnual Review of Biochemistry, 1996
- Novel Tricyclic Inhibitors of Farnesyl Protein TransferasePublished by Elsevier ,1995
- NMR studies of novel inhibitors bound to farnesyl‐protein transferaseProtein Science, 1995
- Ras farnesylation as a target for novel antitumor agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferaseDrug Development Research, 1995
- A Non-peptide Mimetic of Ras-CAAX: Selective Inhibition of Farnesyltransferase and Ras ProcessingPublished by Elsevier ,1995
- Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton.Molecular and Cellular Biology, 1994
- Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal CellsScience, 1993
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993
- Ras C-terminal processing enzymes—New drug targets?Cell, 1991
- ras GENESAnnual Review of Biochemistry, 1987